Table 1. Association between the clinicopathological parameters and mTOR, p-mTOR expression in 120 cases of gastric cancer.

Variable		Total patients	mTOR-positive	mTOR-negative	P value	p-mTOR-positive	p-mTOR-negative	P value
Sex	Male	80	50	30	0.60	46	34	0.30
	Female	40	23	17		19	21
Age	<60y	49	21	28	<0.01	26	23	0.84
	>60y	71	52	19		39	32
Tumor size	<3cm	15	9	6	0.58	9	6	0.63
	>3cm	105	64	41		56	49
Differentiation	Well/moderate	102	60	42	0.28	49	53	<0.01
	Poor	18	13	5		16	2
Tumor location	Upper/Medium	77	49	28	0.40	43	34	0.62
	Low	43	24	19		22	21
Depth of invasion	T1+T2	22	10	12	0.10	6	16	<0.01
	T3+T4	98	63	35		59	39
LN metastasis	N0	25	12	13	0.14	9	16	0.04
	N1+N2+N3	95	61	34		56	39
Metastasis	M0	114	70	44	0.58	63	51	0.53
	M1	6	3	3		2	4
TNM stage	I+II	33	15	18	0.03	12	21	0.02
	III+IV	87	58	29		53	34

LN metastasis: lymph node metastasis. TNM stages are based on tumor-node-metastasis classification advocated by International Union against Cancer.